Establishment Labs Holdings Inc. (ESTA)
USD 33.86
(-18.59%)
USD 33.86
(-18.59%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 172 Million USD | 17.61% |
| 2022 | 146.25 Million USD | 32.3% |
| 2021 | 110.54 Million USD | 37.46% |
| 2020 | 80.41 Million USD | -6.27% |
| 2019 | 85.8 Million USD | 43.05% |
| 2018 | 59.98 Million USD | 59.17% |
| 2017 | 37.68 Million USD | 45.34% |
| 2016 | 25.92 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 33.21 Million USD | -22.22% |
| 2024 Q2 | 38.28 Million USD | 15.25% |
| 2023 Q2 | 43.97 Million USD | 15.0% |
| 2023 Q3 | 47.09 Million USD | 7.09% |
| 2023 Q4 | 42.7 Million USD | -9.32% |
| 2023 Q1 | 38.23 Million USD | -7.47% |
| 2023 FY | 172 Million USD | 17.61% |
| 2022 Q1 | 30.51 Million USD | -9.17% |
| 2022 Q2 | 37.86 Million USD | 24.09% |
| 2022 FY | 146.25 Million USD | 32.3% |
| 2022 Q3 | 36.55 Million USD | -3.44% |
| 2022 Q4 | 41.32 Million USD | 13.04% |
| 2021 Q3 | 28.66 Million USD | 9.82% |
| 2021 Q4 | 33.59 Million USD | 17.19% |
| 2021 Q1 | 22.18 Million USD | -2.1% |
| 2021 FY | 110.54 Million USD | 37.46% |
| 2021 Q2 | 26.1 Million USD | 17.65% |
| 2020 Q1 | 23.18 Million USD | 11.65% |
| 2020 FY | 80.41 Million USD | -6.27% |
| 2020 Q4 | 22.66 Million USD | 27.76% |
| 2020 Q3 | 17.73 Million USD | 5.35% |
| 2020 Q2 | 16.83 Million USD | -27.37% |
| 2019 Q4 | 20.76 Million USD | -9.73% |
| 2019 Q2 | 22.39 Million USD | 14.03% |
| 2019 Q1 | 19.64 Million USD | 6.2% |
| 2019 FY | 85.8 Million USD | 43.05% |
| 2019 Q3 | 23 Million USD | 2.71% |
| 2018 Q4 | 18.49 Million USD | 14.45% |
| 2018 FY | 59.98 Million USD | 59.17% |
| 2018 Q3 | 16.15 Million USD | 11.18% |
| 2018 Q2 | 14.53 Million USD | 34.64% |
| 2018 Q1 | 10.79 Million USD | -3.19% |
| 2017 Q1 | 7.35 Million USD | 0.0% |
| 2017 Q2 | 9.6 Million USD | 30.67% |
| 2017 Q3 | 9.57 Million USD | -0.33% |
| 2017 Q4 | 11.15 Million USD | 16.46% |
| 2017 FY | 37.68 Million USD | 45.34% |
| 2016 FY | 25.92 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -1432.457% |
| Cerus Corporation | 143.15 Million USD | -20.152% |
| OrthoPediatrics Corp. | 137.01 Million USD | -25.532% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -1413.995% |
| Talis Biomedical Corporation | 67.18 Million USD | -156.01% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -589.501% |
| Inogen, Inc. | 236.08 Million USD | 27.144% |
| Spectral AI, Inc. | 20.86 Million USD | -724.401% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -207.165% |
| CVRx, Inc. | 76.14 Million USD | -125.898% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -4775.374% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -1277.236% |
| Orthofix Medical Inc. | 667.42 Million USD | 74.229% |
| Venus Concept Inc. | 80.47 Million USD | -113.732% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -204.01% |
| Bioventus Inc. | 409.91 Million USD | 58.04% |
| BrainsWay Ltd. | 28.01 Million USD | -513.902% |
| Envoy Medical, Inc. | 17.89 Million USD | -861.018% |
| electroCore, Inc. | 32.03 Million USD | -436.989% |
| IceCure Medical Ltd | 16.87 Million USD | -919.217% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -305.362% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -875.459% |
| MaxCyte, Inc. | 84.84 Million USD | -102.726% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -1285.806% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2875.132% |
| PAVmed Inc | 64.82 Million USD | -165.326% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -236.746% |
| RxSight, Inc. | 103.85 Million USD | -65.626% |
| Sight Sciences, Inc. | 126.44 Million USD | -36.026% |
| SI-BONE, Inc. | 156.35 Million USD | -10.011% |
| TELA Bio, Inc. | 84.18 Million USD | -104.311% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -145.522% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 15.422% |
| LivaNova PLC | 843.54 Million USD | 79.61% |
| 908 Devices Inc. | 68.08 Million USD | -152.648% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 64.433% |
| Nemaura Medical Inc. | 7.13 Million USD | -2309.41% |
| NeuroPace, Inc. | 75.29 Million USD | -128.436% |
| LENSAR, Inc. | 33.33 Million USD | -415.968% |
| Apyx Medical Corporation | 51.01 Million USD | -237.142% |
| Cutera, Inc. | 197.72 Million USD | 13.009% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -594.092% |
| BioSig Technologies, Inc. | 28.53 Million USD | -502.885% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 10.169% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -376.991% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 79.435% |
| Axonics, Inc. | 270.2 Million USD | 36.343% |
| Outset Medical, Inc. | 198.77 Million USD | 13.466% |
| IRIDEX Corporation | 31.81 Million USD | -440.652% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 4.559% |
| IRadimed Corporation | 30.12 Million USD | -471.006% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -1915.975% |
| INVO Bioscience, Inc. | 7.85 Million USD | -2090.202% |
| Telesis Bio, Inc. | 63.48 Million USD | -170.918% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -74.706% |
| Varex Imaging Corporation | 224.8 Million USD | 23.486% |
| Quipt Home Medical Corp. | 148.66 Million USD | -15.697% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1367.227% |
| Pulmonx Corporation | 112.68 Million USD | -52.638% |
| Dynatronics Corporation | 9.9 Million USD | -1635.997% |
| Modular Medical, Inc. | 17.52 Million USD | -881.248% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -752.048% |
| Semler Scientific, Inc. | 38.94 Million USD | -341.668% |
| InMode Ltd. | 215.68 Million USD | 20.251% |
| Bruker Corporation | 1.07 Billion USD | 84.021% |
| Cytosorbents Corporation | 48.33 Million USD | -255.842% |
| DexCom, Inc. | 1.69 Billion USD | 89.83% |
| Align Technology, Inc. | 2.07 Billion USD | 91.718% |
| Viveve Medical, Inc. | 22.17 Million USD | -675.732% |
| ZimVie Inc. | 275.12 Million USD | 37.482% |
| Movano Inc. | 29.69 Million USD | -479.33% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -25.302% |
| Nexalin Technology, Inc. | 5.78 Million USD | -2875.132% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -4775.374% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 71.377% |
| Profound Medical Corp. | 33.6 Million USD | -411.866% |
| Insulet Corporation | 939.9 Million USD | 81.7% |
| enVVeno Medical Corporation | 25.23 Million USD | -581.524% |
| Surmodics, Inc. | 98.69 Million USD | -74.274% |
| iCAD, Inc. | 22.22 Million USD | -673.917% |
| Nuwellis, Inc. | 22.61 Million USD | -660.638% |
| Biotricity, Inc. | 17.18 Million USD | -900.917% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 61.425% |
| Aethlon Medical, Inc. | 12.27 Million USD | -1300.96% |
| InspireMD, Inc. | 22.95 Million USD | -649.468% |
| PAVmed Inc. | 64.82 Million USD | -165.326% |
| BIOLASE, Inc. | 34.66 Million USD | -396.244% |
| Beyond Air, Inc. | 61.7 Million USD | -178.773% |
| FONAR Corporation | 28.6 Million USD | -501.311% |
| AxoGen, Inc. | 149.33 Million USD | -15.179% |
| Vivani Medical, Inc. | 26.96 Million USD | -537.875% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 2.874% |
| Inari Medical, Inc. | 448.59 Million USD | 61.657% |
| UFP Technologies, Inc. | 58.08 Million USD | -196.103% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -3390.605% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -2622.303% |
| Tenon Medical, Inc. | 16.96 Million USD | -913.69% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -2226.566% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -290.004% |
| AdaptHealth Corp. | 1.07 Billion USD | 84.044% |
| Sintx Technologies, Inc. | 15.2 Million USD | -1031.524% |
| NanoVibronix, Inc. | 4.97 Million USD | -3358.737% |
| Quanterix Corporation | 118.1 Million USD | -45.642% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -1367.227% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -1090.992% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 56.196% |
| TransMedics Group, Inc. | 182.82 Million USD | 5.917% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -512.874% |
| NeuroMetrix, Inc. | 11.09 Million USD | -1449.725% |
| Hyperfine, Inc. | 52.87 Million USD | -225.32% |
| Biomerica, Inc. | 6.97 Million USD | -2364.933% |
| Bone Biologics Corporation | 9.42 Million USD | -1724.326% |
| AVITA Medical, Inc. | 80.77 Million USD | -112.93% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -1568.116% |
| Silk Road Medical, Inc | 186.35 Million USD | 7.702% |